Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer

Clinical trial NCT07409844 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07409844
Sponsor: Ismail Gögenur
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

DMMR Colorectal Cancer Colon Cancer Stage I Colon Cancer Stage II/III Pembrolizumab Immunotherapy

Start date: 2026-03-01
Primary completion: 2028-03-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.